Abstract:Objective To quantify the changes in blood glucose, blood lipids, blood pressure, and the intima-media thickness (IMT) of large arteries in patients with new-onset type 2 diabetes mellitus who received either intensive multifactorial treatment or conventional treatment. Methods Two-hundred and ten patients with new-onset type 2 diabetes mellitus were randomly assigned to two groups: an intensive treatment group ( n =110) and a conventional treatment group ( n =100). Fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), blood pressure, blood lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C)], and IMTs of large arteries (carotid, iliac, and femoral arteries) were determined before and at one and two years after starting treatment. The patients in the conventional treatment group received routine diabetes management in our outpatient department. Targets were established for patients in the intensive treatment group. Their blood glucose, blood lipids, and blood pressure levels were regularly monitored and therapeutic regimens were adjusted for those whose measurements did not meet the target values until all the parameters met the established targets. Within-group and between-group differences were evaluated. Results A significantly greater percentage of patients in the intensive treatment group had LDL-C levels that reached the target value one year after starting treatment than those in the conventional treatment group (52.04% vs. 33.33%, P <0.05). No significant differences were found between groups for FBG, HbA1c, blood pressure, TG, TC, or HDL-C. The percentages of patients with TG (51.02% vs. 34.48%), TC (52.04% vs. 33.33%), and LDL-C (61.22% vs. 43.67%) who met the respective target values in the intensive treatment group were all significantly higher than the corresponding percentages in the conventional treatment group two years after starting treatment ( P <0.05). There were no significant differences in the percentages of patients with FBG, HbA1c, and blood pressure values meeting the respective targets between the groups at the two-year follow-up. One year after starting treatment, the LDL-C level, diastolic blood pressure (DBP), and the IMTs of the femoral and iliac arteries of the intensive treatment group were significantly lower compared to those of the conventional treatment group ( P <0.05), although there was no significant difference in other metabolic parameters. Two years after starting treatment, the TC, LDL-C, blood pressure [systolic blood pressure (SBP) and DBP], and the IMTs of the carotid and femoral arteries of the intensive treatment group were significantly lower than those of the conventional treatment group ( P <0.05). No significant differences in other metabolic parameters existed between the two groups two years after starting treatment. Conclusions Early comprehensive and intensive treatment of type 2 diabetes mellitus can delay or even reverse the increase in IMT of large arteries. Lowering blood pressure and blood lipid regulation in patients with type 2 diabetes mellitus have great significance in decreasing the risk of diabetes-related macrovascular lesions.

Association of Serum Leptin with Intima-Media Thickness of Carotid Artery in Type 2 Diabetes Patients

Assessments of Correlation Between Intima-Media Thickness and Elasticity of Carotid in Patients with Type 2 Diabetes Accompanied Hyperlipidemia

Relationship of Carotid Intima-media Thickness with Serum High Sensitive C-reactive Protein and Insulin Resistance Risk Factors in Type 2 Diabetes Mellitus

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

The Relationship between Carotid Intima-media Thickness and Plasma LPA Content in Patients with Type 2 Diabetes

High Sensitivity C-reactive Protein is Associated with Carotid Intimal Medial Thickness in Type 2 Diabetes Mellitus

Association between serum 25-hydroxy vitamin D level and carotid intima-media thickness in patients with type 2 diabetes

Association of activation of peripheral T lymphocytes with carotid intima-media thickness in type 2 diabetic patients

A Case-Control Study on Risk Factors of Carotid Intima-Media Thickness (C-IMT) in Patients with Type 2 Diabetes

Serum Osteocalcin Level and Its Association with Carotid Atherosclerosis in Patients with Type 2 Diabetes

Relationship Between Cardial Intima-Media Thickness and Cardiovascular Risk Factors in the Elderly Type 2 Diabetics

Long-term intensive glycemic and lipid control ameliorates the carotid intima medial thickness in type 2 diabetes mellitus

Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes

Relationship between pulse pressure and carotid intima-media thickness in newly diagnosed type 2 diabetes mellitus

The Relationship Between C-reactive Protein and Carotid Intimal Medial Thickness in Patients with Type 2 Diabetes Mellitus

Influence of remnant cholesterol levels on carotid intima thickness in type 2 diabetes patients

Association of Plasma Cystatin C and Intima-Media Thickness of Carotid Artery in Patients with Early Type 2 Diabetes Mellitus

Serum Phospholipid Fatty Acid Spectrum and Its Correclation with Plasma Lipid in Patients with Type 2 Diabetes

Systematic review and meta-analysis assessing the status of carotid intima-media thickness and lipid profiles in type 2 diabetes mellitus

Correlation between carotid intima-media thickness and newly diagnosed diabetic retinopathy

Association between glycated hemoglobin and carotid intima-media thickness in newly diagnosed type 2 diabetes patients